Aptose Biosciences Inc.

2.51-0.0900-3.46%Vol 937.03K1Y Perf -55.38%
Sep 24th, 2021 16:00 DELAYED
BID2.50 ASK2.51
Open2.60 Previous Close2.60
Pre-Market- After-Market2.52
 - -  0.01 0.40%
Target Price
8.75 
Analyst Rating
Strong Buy 1.00
Potential %
248.61 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
100/-33/-50 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
100/-61/-72 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
100/-61/-70 
Income Ranking
 —    -
Price Range Ratio 52W %
3.84 
Earnings Rating
Strong Buy
Market Cap223.26M 
Earnings Date
9th Nov 2021
Alpha0.01 Standard Deviation0.25
Beta1.72 

Today's Price Range

2.472.63

52W Range

2.327.27

5 Year PE Ratio Range

-7.40-2.10

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-6.69%
1 Month
-9.06%
3 Months
-26.18%
6 Months
-57.31%
1 Year
-55.38%
3 Years
-5.99%
5 Years
16.74%
10 Years
-

TickerPriceChg.Chg.%
APTO2.51-0.0900-3.46
AAPL146.920.09000.06
GOOG2 852.6616.13000.57
MSFT299.35-0.2100-0.07
XOM57.590.51000.89
WFC47.920.12000.25
JNJ164.36-0.5000-0.30
FB352.967.00002.02
GE103.800.84000.82
JPM163.041.86001.15
Earnings HistoryEstimateReportedSurprise %
Q02 2021-0.18-0.1516.67
Q01 2021-0.17-0.18-5.88
Q04 2020-0.16-0.17-6.25
Q03 2020-0.18-0.1516.67
Q02 2020-0.15-0.21-40.00
Q01 2020-0.10-0.15-50.00
Q04 2019-0.14-0.137.14
Q03 2019-0.13-0.127.69
Earnings Per EndEstimateRevision %Trend
9/2021 QR-0.1715.00Positive
12/2021 QR-0.199.52Positive
12/2021 FY-0.6812.82Positive
12/2022 FY-0.928.91Positive
Next Report Date9th Nov 2021
Estimated EPS Next Report-0.17
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume937.03K
Shares Outstanding88.95M
Shares Float88.10M
Trades Count3.40K
Dollar Volume5.43M
Avg. Volume2.19M
Avg. Weekly Volume786.16K
Avg. Monthly Volume811.45K
Avg. Quarterly Volume1.03M

Aptose Biosciences Inc. (NASDAQ: APTO) stock closed at 2.51 per share at the end of the most recent trading day (a -3.46% change compared to the prior day closing price) with a volume of 938.10K shares and market capitalization of 223.26M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 31 people. Aptose Biosciences Inc. CEO is William G. Rice.

The one-year performance of Aptose Biosciences Inc. stock is -55.38%, while year-to-date (YTD) performance is -42.69%. APTO stock has a five-year performance of 16.74%. Its 52-week range is between 2.32 and 7.27, which gives APTO stock a 52-week price range ratio of 3.84%

Aptose Biosciences Inc. currently has a PE ratio of -4.40, a price-to-book (PB) ratio of 2.49, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -58.76%, a ROC of -64.38% and a ROE of -63.44%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Aptose Biosciences Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.17 for the next earnings report. Aptose Biosciences Inc.’s next earnings report date is 09th Nov 2021.

The consensus rating of Wall Street analysts for Aptose Biosciences Inc. is Strong Buy (1), with a target price of $8.75, which is +248.61% compared to the current price. The earnings rating for Aptose Biosciences Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Aptose Biosciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Aptose Biosciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 14.69, ATR14 : 0.14, CCI20 : -123.53, Chaikin Money Flow : -0.12, MACD : -0.07, Money Flow Index : 24.70, ROC : -14.63, RSI : 37.22, STOCH (14,3) : 7.14, STOCH RSI : 0.00, UO : 40.96, Williams %R : -92.86), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Aptose Biosciences Inc. in the last 12-months were: Warren Whitehead (Option Excercise at a value of $40 200), Warren Whitehead (Sold 35 000 shares of value $123 794 ), William G. Rice (Buy at a value of $19 998)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
4 (100.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Aptose Biosciences Inc.

Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm has CG-806, APTO-253 drugs in preclinical development stage pipeline.

CEO: William G. Rice

Telephone: +1 650 718-5028

Address: 251 Consumers Road, Toronto M2J 4R3, ON, CA

Number of employees: 31

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

55%45%

Bearish Bullish

63%37%

News

Stocktwits